Pediatric Neurology
Volume 27, Issue 2 , Pages 117-122 , August 2002

Brain glucose metabolism in Rett Syndrome

  • Patricia M Villemagne, MD

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • Sakkubai Naidu, MD

      Affiliations

    • Kennedy Krieger Institute, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • Victor L Villemagne, MD

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • Myron Yaster, MD

      Affiliations

    • Department of Anesthesiology; Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • Henry N Wagner Jr, MD

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • James C Harris, MD

      Affiliations

    • Kennedy Krieger Institute, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • Hugo W Moser, MD

      Affiliations

    • Kennedy Krieger Institute, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • Michael V Johnston, MD

      Affiliations

    • Kennedy Krieger Institute, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • Robert F Dannals, PhD

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • ,
  • Dean F Wong, MD, PhD

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions; Baltimore, Maryland, USA
    • Corresponding Author InformationCommunications should be addressed to: Dr. Wong; JHOC Research Room 3245; Johns Hopkins Medical Institutions; 601 North Caroline Street; Baltimore, MD 21287-0807, USA.

Received 29 June 2001 ,Accepted 14 February 2002.

References 

  1. Rett A. Uber ein eiggenatiges hirnatrophisches syndrome bei hyperammonamie in kindersalter. Wien Ned Wochenschr. 1966;116:723–736
  2. Schanen NC. Molecular approaches to the Rett syndrome gene. J Child Neurol. 1999;14:806–814
  3. Olsson B, Rett A. Autism and Rett syndrome (Behavioural investigations and differential diagnosis). Dev Med Child Neurol. 1987;29:429–441
  4. Sirianni N, Naidu S, Pereira J, Pillotto RF, Hoffman EP. Rett syndrome (Confirmation of X-linked dominant inheritance, and localization on the gene to Xq28). Am J Hum Genet. 1998;63:1552–1558
  5. Percy AK. Genetics of Rett syndrome (Properties of the newly discovered gene and pathobiology of the disorder). Curr Opin Pediatr. 2000;12:589–595
  6. Couvert P, Bienvenu T, et al.  MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 2001;10:941–946
  7. Armstrong DD. The neuropathology of Rett syndrome--overview 1994. Neuropediatrics. 1995;26:100–104
  8. Naidu S. Rett Syndrome (A disorder affecting early brain growth). Ann Neurol. 1997;42:3–10
  9. Bauman ML, Kemper TK, Arin DM. Microscopic observations of the brain in Rett syndrome. Neuropediatrics. 1995;26:105–108
  10. Armstrong DD, Dunn K, Antalffy B. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol. 1998;57:1013–1017
  11. Kaufman WE, Moser HW. Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex. 2000;10:981–991
  12. Naidu S, Murphy M, Moser HW, Rett A. Rett syndrome-natural history in 70 cases. Am J Med Genet. 1986;1:61–72
  13. Nihei K, Naitoh H. Cranial computed tomographic and magnetic resonance imaging studies on the Rett syndrome. Brain Dev. 1990;12:101–105
  14. Reiss AL, Faruque F, Naidu S, et al.  Neuroanatomy of Rett syndrome (A volumetric imaging study). Ann Neurol. 1993;34:227–234
  15. Subramanian B, Naidu S, Reiss AL. Neuroanatomy in Rett syndrome (Cerebral cortex and posterior fossa). Neurology. 1997;48:399–407
  16. Harris JC, Wong DF, Wagner HN, et al.  Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome. Am J Med Genet Suppl. 1986;1:201–210
  17. Wong DF, Harris JC, Naidu S, et al.  Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA. 1996;93:5539–5543
  18. Yamashita Y, Matsuishi T, Ishibashi M, et al.  Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome. J Neurol Sci. 1998;154:146–150
  19. Blue ME, Naidu S, Johnston MV. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol. 1999;156:345–352
  20. Blue ME, Naidu S, Johnston MV. Development of aminoacid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol. 1999;45:541–545
  21. Wenk GL, Naidu S, Casanova MF, Kitt CA, Moser H. Altered neurochemical markers in Rett syndrome. Neurology. 1991;41:1753–1756
  22. Yoshikawa H, Fueki N, Suzuki H, Sakuragawa N, Lio M. Cerebral blood flow and oxygen metabolism in the Rett syndrome. Brain Dev. 1992;14(Suppl):S69–74
  23. Nielsen JB, Friberg L, Lou H, Lassen NA, Sam IL. Immature pattern of brain activity in Rett syndrome. Arch Neurol. 1990;47:982–986
  24. Burroni L, Aucone AM, Volerrani D, et al.  Brain perfusion abnormalities in Rett syndrome (A qualitative SPET study with 99Tc(m)-ECD). Nuclear Med Commun. 1997;18:527–534
  25. Lappalainen R, Liewendahl K, Sainio K, Nikkinen P, Riikonen RS. Brain perfusion SPECT and EEG findings in Rett syndrome. Acta Neurol Scand. 1997;95:44–50
  26. Bjure J, Uvebrant P, Vestergren E, Hagberg B. Regional cerebral blood flow abnormalities in Rett syndrome. Eur Child Adolesc Psychiatry. 1997;6(Suppl 1):64–66
  27. Chugani HT, Phelps ME. Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science. 1986;231:840–843
  28. Chugani HT, Phelps ME, Mazziota JC. Positron emission tomography study of human brain functional development. Ann Neurol. 1987;22:487–497
  29. Chugani HT, Chugani DC. Basic mechanisms of childhood epilepsies (Studies with positron emission tomography). Adv Neurol. 1999;79:883–891
  30. Juhasz C, Nagy F, Watson C, et al.  Glucose and [11C] flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology. 1999;53:2037–2045
  31. Shapiro MB. Decline in cerebral glucose utilization and cognitive function with aging in Down’s syndrome. J Neurol Neurosurg Psychiatry. 1987;50:766–774
  32. Schifter T, Hoffman JM, Hatten Jr HP, Hanson MW, Coleman RE, DeLong GR. Neuroimaging in infantile autism. J Child Neurol. 1999;9:155–161
  33. Eidelberg D, Moeller JR, Antonini A, Kazumata K, Dhawan V, Budman C, et al. The metabolic anatomy of Tourette’s syndrome. Neurology. 1997;48:927–934
  34. The Rett Syndrome Diagnostic Criteria Work Group . Diagnostic criteria for Rett syndrome. Ann Neurol. 1988;23:425–428
  35. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of non-carrier added 2-[18F]-fluoro-2-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic susbtitution. J Nuc Med. 1986;27:235–238
  36. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurements of local cerebral glucose metabolic rate in humans with (F-18) 2-Fluoro-2-Deoxy-D-glucose validation of method. Ann Neurol. 1979;6:371–388
  37. Duara R, Grady C, Haxby J, et al.  Positron emission tomography in Alzheimer’s disease. Neurology. 1986;36:879–887
  38. Gur RE, Resnick SM, Alavi A, et al.  Regional brain function in schizophrenia. Arch Gen Psychyatry. 1987;44:119–125
  39. Friedland RF, Budinger TF, Koss E, Ober BA. Alzheimer’s disease (Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization). Neurosci Lett. 1985;53:235–240
  40. Hibbard LS, McGlone JS, Davis DW, Hawkins RA. Three-dimensional representation and analysis of brain energy metabolism. Science. 1987;236:1641–1646
  41. Theodore WH, Di Chiro G, Margolin R, Fishbein D, Porter RJ, Brooks RA. Barbiturates reduce human cerebral glucose metabolism. Neurology. 1986;36:60–64
  42. Magistretti PJ. Cellular bases of functional brain imaging (Insights from neuron-glia metabolic coupling). Brain Res. 2000;886:108–112
  43. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science. 1999;283:496–497
  44. Niedermeyer E, Naidu SB, Plate C. Unusual theta rhythm over central region in Rett syndrome (Considerations of the underlying dysfunction). Clin Electroencephalogr. 1997;28:36–43
  45. Chugani HT. Positron emission tomography in mitochondrial diseases. Biofactors. 1998;7:255–257
  46. Nariai T, Ohno K, Akimoto H, et al.  Cerebral blood flow, vascular response and metabolism in patients with MELAS syndrome--xenon CT and PET study. Keio J Med. 2000;49(Suppl 1):A68–70
  47. Sano MI, Mosome Y, Uchigata M, Senda M. Cerebral metabolism of oxygen and glucose in a patient with MELAS syndrome. Acta Neurol Scand. 1995;92:497–502
  48. Frackowiack RS, Herold S, Petty RK, Morgan-Hughes JA. The cerebral metabolism of glucose and oxygen measured with positron emission tomography in patients with mitochondrial diseases. Brain. 1988;111:1009–1024
  49. Glaze GG, Frost JD, Zoghbi HY, Percy AK. Rett’s syndrome (Correlation of electroencephalographic characteristics with clinical staging). Arch Neurol. 1987;44:1053–1056
  50. Molnar MJ, Valikovics A, Molnar S, et al.  Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology. 2000;55:544–548
  51. Cornford ME, Philippart M, Jacobs B, Scheibel AB, Vinters HV. Neuropathology of Rett syndrome (Case report with neuronal and mitochondrial abnormalities in the brain). J Child Neurol. 1994;9:424–431
  52. Cardaioli E, Dotti MT, Hayek G, Zappella M, Federico A. Studies on mitochondrial pathogenesis of Rett Syndrome (Ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835). J Submicrosc Cytol Pathol. 1999;31:301–304
  53. Haas RH, Light M, Rice M, Barshop BA. Oxidative metabolism in Rett syndrome (1. Clinical studies). Neuropediatrics. 1995;26:90–94
  54. Matsuishi T, Urabe F, Percy AK, et al.  Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome. J Child Neurol. 1994;9:26–30
  55. Heh C, Smith R, Wu J, et al.  Positron emission tomography of the cerebellum in autism. Am J Psychiatry. 1989;146:242–245
  56. Murakami JW, Courchesne E, Haas RH, Press GA, Yeung-Courchesne R. Cerebellar and cerebral abnormalities in Rett syndrome. Am J Roentgenol. 1992;159:177–183
  57. Oldfors A, Sourander P, Armstrong DL, Percy AK, Witt-Engerstrom I, Hagberg BA. Rett syndrome (Cerebellar pathology). Pediatric Neurol. 1990;6:310–314
  58. Duara R, Grady C, Haxby J, et al.  Positron emission tomography in Alzheimer’s disease. Neurology. 1986;36:879–887
  59. Hoffman JM, Welsh-Bohner KA, Hanson M, et al.  FDG PET imaging in patients with pathologically verified dementia. J Nucl Med. 2000;41:1920–1928
  60. Schapiro MB, Grady CL, Kumar A, et al.  Regional cerebral glucose metabolism is normal in young adults with Down syndrome. J Cereb Blood Flow Metab. 1990;10:199–206
  61. Rumsey JM, Duara R, Grady C, et al.  Brain metabolism in autism (Resting cerebral glucose utilization rates as measured with positron emission tomography). Arch Gen Psychiatry. 1985;42:448–455
  62. Horwitz B, Rumsey JH, Grady CL, Rapoport SI. The cerebral metabolic landscape in autism (Intercorrelation of regional glucose utilization). Arch Neurol. 1988;45:749–755
  63. Rumsey JM, Ernst M. Functional neuroimaging of autistic disorders. Ment Retard Dev Disabil Res Rev. 2000;6:171–179

PII: S0887-8994(02)00399-5

Pediatric Neurology
Volume 27, Issue 2 , Pages 117-122 , August 2002

Article Tools

* Image Usage & Resolution